Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 4, 2000, Pages 287-300

  Warnick, G Russel ^a,b  

^a Pac Biomedrics Research Foundation   (United States)

^b Pac Biometrics Research Foundation   (United States)

Author keywords

Cholesterol; Coronary artery disease; HDL high density lipoprotein; LDL low density lipoprotein; Lipid standardization; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; CARDIOVASCULAR DISEASE; CASE FINDING; CLINICAL LABORATORY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; EDUCATION; ERROR; HUMAN; LABORATORY AUTOMATION; MEASUREMENT; METHODOLOGY; PRACTICE GUIDELINE; PREDICTION; PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STANDARDIZATION; UNITED STATES;

EID: 0033934627     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.041     Document Type: Review

References (104)

1. National Cholesterol Education Program, Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Am Med Assoc 1993; 260:3015.
2. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Task Force of European and other Societies on Coronary Prevention 1998.
3. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80:S1-S29.
4. American Heart Association. Consensus Panel Statement. Guide to Primary Prevention of Cardiovascular Diseases, Circulation 1997; 95:2330.
5. National Cholesterol Education Program, Report of the expert panel on blood cholesterol levels in children and adolescents. Bethesda, Maryland: NIH Publication 1991:91-2732.
6. National Cholesterol Education Program Laboratory Standardization Panel. Current status of blood cholesterol measurements in clinical laboratories in the United States. Clin Chem 1988; 34:193-201.
7. Report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Recommendations for improving cholesterol measurement. Bethesda, Maryland: NIH publication 1990:90-2964.
8. National Cholesterol Education Program Working Group on Lipoprotein Measurement. Recommendations on lipoprotein measurement. Bethesda, Maryland: NIH Publication 1995:95:3044.
9. Warnick GR, Wood P. National Cholesterol Education program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. Clin Chem 1995; 41:1427-33.
10. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 1995; 41:1414-20.
11. Stein EV, Myers GL. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. Clin Chem 1995; 41:1421-6
12. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction.) J Am Coll Cardiol 1996; 28:1328-428.
13. Hokanson JE, Austin MA. Plasma triglyceride level as a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996; 1996:3:312-9.
14. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. J Am Med Assoc 1993; 269:505-10.
15. Caudill SP, Cooper GR, Smith SJ, Myers GL. Assessment of current National Cholesterol Education Program guidelines for total cholesterol triglyceride, HDL-cholesterol, and LDL-cholesterol measurements. Clin Chem 1998; 44:1650-8.
16. Miller WG. Matrix effects in the measurement and standardization of lipids and lipoproteins. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:199-221.
17. Ellerbe P, Meiselmann S, Sniegoski LT, Welch MJ, White E. Determination of serum cholesterol by a modification of the isotope dilution mass spectrometric definitive method. Anal Chem 1989; 61:1718-23.
18. Meyers GL, Cooper GR, Winn CL, Smith SJ. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med 1989; 9:105-35.
19. Stockl D, Reinauer H. Candidate reference methods for determining target values for cholesterol, creatinine, uric acid, and glucose in external quality assessment and internal accuracy control. I. Method setup. Clin Chem 1993; 39:993-1000.
20. Thienpont LM, VanLanduyt KG, Stockl D, DeLeenheer AP. Four frequently used test systems for serum cholesterol evaluated by isotope dilution gas chromatography-mass spectrometry candidate reference method. Clin Chem 1996; 42:531-5.
21. Myers GL, Cooper GR, Henderson LO, Hassemer DJ, Kimberly MM. Standardization of lipid and lipoprotein measurement. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:223-50.
22. Eckfeldt J H, Copeland K R. Accuracy verification and identification of matrix effects. Arch Pathol Lab Med 1993; 117:381-6.
23. Warnick GR, Spain M, Kloepfer H, Volke TM. Standardization of a commercial (Boehringer Mannheim Diagnostics) enzymic method for cholesterol. Clin Chem 1989; 35:405-13.
24. Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood and lipid measurements variations and practical utility. J Am Med Assoc 1992; 267:1652-1660.
25. Rifai N, Dufour R, Cooper GR. Preanalytical variation in lipid, lipoprotein, and apolipoprotein testing. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:75-97.
26. Zak B. Cholesterol methodologies: a review. Clin Chem 1977; 23:1201-14.
27. Artiss JD, Zak B. Measurement of cholesterol concentration. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:99-114.
28. Allain CC, Poon LS, Chan CS, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20:470.
29. Wiebe DA, Bernert Jr JT. Influence of incomplete cholesteryl ester hydrolysis on enzymic measurements of cholesterol. Clin Chem 1984; 30:352-6.
30. Burstein M, Legmann P. Lipoprotein precipitation. In: Clarkson, TB, Kritchevsky D, Pollak OJ, editors. Monographs on atherosclerosis. New York: S. Karger, 1982:2:1.
31. Wiebe DA, Warnick GR. Measurement of high-density lipoprotein cholesterol. In: Handbook of lipoprotein testing. Rifai N, Warnick GR, Dominiczak MH, editors. Washington DC: AACC Press 1997:127-44.
32. Burstein M, Samaille J. Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoproteines du serum. Clin Chim Acta 1960; 5:609.
33. Fredrickson DS, Levy RI, Lindgren FT. A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest 1968; 47:2446-57.
34. Manual of laboratory operations, lipid research clinics program, lipid and lipoprotein analysis. Washington DC. Revised 1983. NIH, US Department of Health and Human Services.
35. Steele BW, Koehler DF, Azar MM, Blaszkowski TP, Kuba K, Dempsey ME. Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem 1976; 22:98-101.
36. Burstein M, Scholnick HR. Lipoprotein-polyanion-metal interactions. Adv Lipid Res 1973; 11:68-105.
37. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23:882-4.
38. Warnick GR, Cheung MC, Albers JJ. Comparison of current methods for high-density lipoprotein cholesterol quantitation. Clin Chem 1979; 25:596-604.
39. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982; 28:1379-88.
40. Vikari J. Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest 1976; 36:265-8.
41. Allen JK, Hensley WJ, Nicholls AV, Whitfield JB. An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem 1979; 25:325-7.
42. Demacker PN, Vos-Janssen HE, Hijmans AG, Van't Laar A, Jansen AP. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods combined with enzymic cholesterol analysis. Clin Chem 1980A; 26:1780-6.
43. Warnick GR, Albers JJ, Bachorik PS, et al. Multi-laboratory evaluation of an ultrafiltration procedure for high density lipoprotein cholesterol quantification in turbid heparin-manganese supernates. J Lipid Res 1981; 22:1015-9.
44. Naito HK, Kwak YS. The evaluation of a new high-density lipoprotein cholesterol (HDL-C) technology: selective separation of lipoproteins by magnetic separation. Clin Chem 1995; 41S:135.
45. Kakuyama T, Kimura S, Hasiguchi Y. Fully automated determination of HDL-cholesterol from human serum with hitachi911 [abstract]. Clin Chem 1994; 40:1104
46. Nauck M, Marz W, Haas B, Wieland H. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated. Clin Chem 1996; 42:424-9.
47. Sugiuchi H, Irie T, Uji Y, Ueno T, Chaen T, Uekama K, et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate. Clin Chem 1998; 44:522-31.
48. Harris N, Galpchian V, Rafai N. Three routine methods for measuring high-density lipoprotein cholesterol compared with the Reference Method. Clin Chem 1996; 42:738-43.
49. Lin MJ, Hoke C, Ettinger B. Evaluation of homogeneous high-density lipoprotein cholesterol assay on a BM/Hitachi 747-200 Analyzer. Clin Chem 1998; 44:1050-2.
50. Nauck M, März W, Wieland H. New immunoseparation-based homogeneous assay for HDL-cholesterol compared with three homogeneous and two heterogeneous methods for HDL-cholesterol. Clin Chem 1998; 44:1443-
51. Lawlor J, Pelczar D, Sane R, Siek G., Performance characteristics of the RDI homogeneous HDL cholesterol assay [abstract]. Clin Chem 1998:44A:79.
52. Halloran P, Roetering H, Pisani T, van den Berg B, Cobbaert C. Reference standardization and analytical performance of a liquid homogeneous hdl-cholesterol method compared to a chemical precipitation method. Archives of Path & Lab Med 1999; 23 (In Press).
53. College of American Pathologists Proficiency Survey Reports, C30, 977, 1998, Chicago IL.
54. Okazaki M, Sasamoto K, Muramatsu T, Hosaki S. Evaluation of precipitation and direct methods for HDL-cholesterol assay by HPLC. Clin Chem 1997; 43:1885-90.
55. Arranz-Pena ML, Tasende-Mata J, Martin-Gil FJ. Comparison of two homogeneous assays with a precipitation method and an ultracentrifugation method for the measurement of HDL-cholesterol. Clin Chem 1998; 44:2499-505.
56. 2+ method. Clin Chem 1997; 43:816-23.
57. Cobbaert C, Zwang L, Ceriotti F, Modenese A, Cremer P, Herrmann W, et al. Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay. Clin Chem 1998; 44:779-89.
58. Hoang MP, Hirany SV, Parupia J, Devaraj S, Jialal I. Comparison of 2 homogeneous high-density lipoprotein cholesterol assays. Arch Pathol Lab Med 1998; 122:1005-9.
59. Hubbard RS, Hirany SV, Devaraj S, Martin L, Parupia J, Jialal I. Evaluation of a rapid homogeneous method for direct measurement of high-density lipoprotein cholesterol. Am J Clin Pathol 1998; 110:495-502.
60. Simó JM, Castellano I, Ferré N, Joven J, Camps J. Evaluation of a homogeneous assay for high-density lipoprotein cholesterol: limitations in patients with cardiovascular, renal, and hepatic disorders. Clin Chem 1998; 44:1233-41.
61. Lackner KJ, Schmitz G. β-VLDL of patients with type iii hyperlipoproteinemia interferes with homogeneous determination of hdl-cholesterol based on polyethylene glycol-modified enzymes. Clin Chem 1998; 44:2546-8.
62. Kimberly MM, Waymack PP, Myers GL, Cole TG, Ferguson C, Gibson D, et al. Comparison of precipitation methods for determination of HDL cholesterol in the Cholesterol Reference Method Laboratory Network [abstract]. Clin Chem 1994; 40:1105.
63. Bachorik PS. Measurement of low-density lipoprotein cholesterol. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:145-60.
64. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
65. Demackeer PN, Toenbake-Dijkstra H, deRijke YB, Stalenhoef AF, Stuyt PM, Willems HL. On the presumed inaccuracy of the friedeward formula in hypertriglyceridemic plasma: a role of imprecise analysis? Clin Chem 1996; 42:1491-4.
66. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990; 36:15-9.
67. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990; 36:36-42.
68. Rifai N, Warnick GR, McNamara JR, Belcher JD, Grinstead GF, Frantz Jr. ID Measurement of low-density-lipoprotein cholesterol in serum: a status report. Clin Chem 1992; 38:150.
69. Leary ET, Tjersland G, Warnick GR. Evaluation of the Genzyme immunoseparation reagent for direct quantitation of LDL cholesterol [abstract]. Clin Chem 1993; 39:1124.
70. Devaraj S, Hirany SV, Sherwood TZ, Jialal I. Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta quantification [abstract]. Clin Chem 1995; 41S:141.
71. Harris N, Neufeld EJ, Newburger JW, Tich B, Baker A, Ginsburg GS, et al. Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyper-lipidemic pediatric population. Clin Chem 1996; 42:1182-8.
72. McNamara JR, Cole TG, Contois JH, Furguson CA, Ordovas JM, Schaefer EJ. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin Chem 1995; 41:232-40.
73. Nakamura M, Sato S, Iida M. Comparison of LDL-cholesterol in fresh and frozen samples by five homogeneous methods in japan [abstract]. Clin Chem 1998; 44S:A80.
74. Sugiuchi H, Irie T, Uji Y, Ueno T, Chaen T, Uekama K, et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate. Clin Chem 1998; 44:522-31.
75. 2+ method. Clin Chem 1998; 44:1242-50.
76. Okada M, Matsui H, Ito Y, Fujiwara A, Inano K. Low-density lipoprotein cholesterol can be chemically measured: a new superior method. J Lab Clin Med 1998; 132:195-201.
77. Lewis LA, Opplt JJ. CRC Handbook of electrophoresis. Volume 1. Boca Raton: CRC Press, Inc. 1980.
78. Lewis LA, Opplt JJ. CRC Handbook of electrophoresis. Volume 2. Boca Raton: CRC Press, Inc. 1980.
79. Papadopoulos, NM. Hyperlipoproteinemia phenotype determination by agarose gel electrophoresis updated. Clin Chem 1978; 24:227-9.
80. Warnick GR, Leary ET, Goetsch J. Electrophoretic quantification of LDL-cholesterol using the Helena REP [abstract]. Clin Chem 1993; 39:1122.
81. Cole TG, Klotzsch SG, McNamara JR. Measurement of triglyceride concentration. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:115-25.
82. Bucolo G, Yabut J, Chang T Y. Mechanized enzymatic determination of triglycerides in serum. Clin Chem 1975; 21:420-4.
83. McGowan M, Artiss J, Strandbergh DR, Zak, B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983; 29:538-42.
84. Stinshoff K, Weisshaar D, Staehler F, Hesse D, Gruber W, Steier E. Relation between concentrations of free glycerol and triglycerides in human sera. Clin Chem 1977; 23:1029-32.
85. Cole TG. Glycerol blanking in triglyceride assays: is it necessary? Clin Chem 1990; 36:1267.
86. Warnick G. Enzymatic methods for quantification of lipoprotein lipids. In: Albers JJ, Segrest JP, editors. Methods in enzymology. Orlando: Academic Press, 1986: 129:101.
87. Sullivan DR, Kruijswijk Z, West CE, Kohlmeier M, Katan MB. Determination of serum triglycerides by an accurate enzymatic method not affected by free glycerol. Clin Chem 1985; 31:1227-8.
88. Lofland Jr HB. A semiautomated procedure for the determination of triglycerides in serum. Anal Biochem 1964; 9:393-400.
89. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88:2762-70.
90. Havel RJ. Triglyceride-rich lipoprotein remnants. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:465-75.
91. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Tada N, et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immunoaffinity mixed gels. Clin Chem 1993; 223:53-71.
92. Leary ET, Wang T, Baker DJ, Cilla DD, Zhong J, Warnick GR, et al. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin Chem 1998; 44:2490-8.
93. McNamara JR, Shah PK, Nakajima K, Cupples A, Wilson PW, Ordovas JM, et al. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study. Clin Chem 1998; 44:1224-32.
94. Warnick GR. Compact analysis systems for cholesterol, triglycerides and high-density lipoprotein cholesterol. Curr Opinion Lipidology 1991; 2:343-8.
95. Bachorik PS. Lipid and lipoprotein analysis with desk-top analyzers. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:161-76.
96. Rogrers EJ, Misner L, Ockene IS, Nicolosi RJ. Evaluation of seven cholestech LDX analyzers for total cholesterol determinations. Clin Chem 1993; 39:860-4.
97. Kafonek SD, Donovan L, Lovejoy KL, Bachorik PS. Biological variation of lipids and lipoproteins in fingerstick blood. Clin Chem 1996; 42:2002-7.
98. Labeur C, Shepherd J, Rosseneu M. Immunological assays of apolipoproteins in plasma: methods and instrumentation. Clin Chem 1990; 36:591-7.
99. Bhatnagar D, Durrington PN. Measurement and clinical significance of apolipoproteins A-1 and B. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:177-98.
100. Sniderman AD. Is it time to measure apolipoprotein B? Arteriosclerosis 1990; 10:665-7.
101. Vega GL, Grundy SM. Does measurement of apolipoprotein B have a place in cholesterol management? Arteriosclerosis 1990; 10:558-671.
102. Marcovina SM, Koschinsky ML, Lipoprotein(a): structure, measurement, and clinical significance. In: Rifai N, Warnick GR, Dominiczak MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:283-314.
103. Tate J, Berg K, Conderc R, Dati F, Kostner GM, Marcovina S, et al. International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a) phase 2. Selection and properties of a proposed secondary reference material for lipoprotein(a). CCLM 1999; 949-58.
104. Sacks TM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001-9.